These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more. Hollenberg MD Life Sci; 2003 Dec; 74(2-3):237-46. PubMed ID: 14607251 [TBL] [Abstract][Full Text] [Related]
24. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Luo W; Wang Y; Reiser G Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333 [TBL] [Abstract][Full Text] [Related]
25. Getting the message across: pathophysiology and signaling via receptors for polypeptide hormones and proteinases. Hollenberg MD Clin Invest Med; 2010 Apr; 33(2):E133. PubMed ID: 20370993 [TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain. Rohatgi T; Sedehizade F; Reymann KG; Reiser G Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036 [TBL] [Abstract][Full Text] [Related]
27. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296 [TBL] [Abstract][Full Text] [Related]
28. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286 [TBL] [Abstract][Full Text] [Related]
34. Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/pathological roles. Kawabata A; Kawao N J Pharmacol Sci; 2005 Jan; 97(1):20-4. PubMed ID: 15655298 [TBL] [Abstract][Full Text] [Related]
35. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179 [TBL] [Abstract][Full Text] [Related]
36. Shooting for PARs in lung diseases. Moffatt JD; Page CP; Laurent GJ Curr Opin Pharmacol; 2004 Jun; 4(3):221-9. PubMed ID: 15140412 [TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptors: novel PARtners in innate immunity. Shpacovitch V; Feld M; Bunnett NW; Steinhoff M Trends Immunol; 2007 Dec; 28(12):541-50. PubMed ID: 17977790 [TBL] [Abstract][Full Text] [Related]
39. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. Hirano K Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):27-36. PubMed ID: 17095716 [TBL] [Abstract][Full Text] [Related]
40. Challenges and Opportunities in Protease-Activated Receptor Drug Development. Hamilton JR; Trejo J Annu Rev Pharmacol Toxicol; 2017 Jan; 57():349-373. PubMed ID: 27618736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]